Life

Health, science, climate, and society-focused reporting.

U.S. Approval Granted for Novo Nordisk's High-Dose Wegovy

The U.S. has approved a high-dose formulation of Wegovy, an injectable drug from Novo Nordisk designed for obesity treatment, indicating a potential shift in treatment protocols.

Editorial Staff Mar 19

Life

Eli Lilly's 'triple-G' Drug Demonstrates Potency Amid Concerns

Eli Lilly's 'triple-G' drug has shown significant potency, while advancements in In-vivo CAR-T therapy are moving closer to clinical application, raising important considerations.

Editorial Staff Mar 19

Life

Apple Watch Utilized in Clinical Trial for Parkinson’s Drug

A biotech firm is integrating Apple Watch technology into its clinical trial for a Parkinson's drug, aiming to enhance data collection and patient monitoring.

Editorial Staff Mar 19

Life

Potential Undercount of Covid Deaths Raises Concerns

Recent discussions suggest the U.S. may have underreported Covid-19 deaths by up to 155,000, highlighting significant implications for public health data accuracy and response strategies.

Editorial Staff Mar 19

Life

Eli Lilly's Investigational Drug Demonstrates Efficacy in Diabetes Management

In a late-stage study, Eli Lilly's investigational drug has shown significant reductions in blood sugar levels and weight among diabetes patients, indicating potential shifts in treatment paradigms.

Editorial Staff Mar 19

Life

Eli Lilly's Investigational Drug Shows Promising Results in Diabetes Management

In a late-stage trial, Eli Lilly's investigational drug demonstrated substantial reductions in blood sugar levels and weight among diabetes patients, indicating potential advancements in diabetes treatment.

Editorial Staff Mar 19

Life

FDA Regulatory Landscape Post-Prasad: Implications for Rare-Disease Drug Approvals

The impending departure of Vinay Prasad raises questions about potential shifts in the FDA's regulatory framework for rare-disease drugs, impacting drugmakers and market dynamics.

Editorial Staff Mar 19

Life

KFF Survey Highlights Cost and Coverage Changes for ACA Marketplace Enrollees in 2025

A recent KFF survey reveals significant cost concerns and coverage changes among ACA Marketplace enrollees in 2025, following the end of enhanced benefits.

Editorial Staff Mar 19

Life

KFF Survey Highlights Impact of Enhanced Tax Credit Expiration on Marketplace Costs

A recent KFF survey shows that 51% of returning Marketplace enrollees are experiencing increased costs following the end of enhanced premium tax credits, prompting potential adjustments in household spending.

Editorial Staff Mar 19

Life

Senate Democrats Propose Health Insurance Overhaul Amid Midterm Challenges

As the midterms approach, Senate Democrats are refining their health care strategy following previous setbacks during the Trump administration.

Editorial Staff Mar 19

Life

HHS Watchdog Reports Antipsychotic Drug Misuse in Nursing Homes

A recent report highlights the misuse of antipsychotic medications in nursing homes, where treatments for dementia are misrepresented as care for schizophrenia.

Editorial Staff Mar 19

Life

Leadership Change in FDA’s Infectious Disease Office

Adam Sherwat, director of the Office of Infectious Diseases at the FDA, is set to leave the agency, impacting ongoing drug evaluation processes.

Editorial Staff Mar 18

Life

Study Reveals Over 150,000 Uncounted Covid-19 Deaths in Early Pandemic Phase

A recent study indicates that the early death toll from Covid-19 in the U.S. exceeded official counts by over 150,000, highlighting significant gaps in data collection.

Editorial Staff Mar 18

Life

Maryland Legislation Seeks Pharma Transparency in Disease Awareness Initiatives

A proposed bill in Maryland mandates that pharmaceutical companies and patient organizations disclose their affiliations with disease awareness campaigns, aiming to improve transparency.

Editorial Staff Mar 18

Life

Advancements in In Vivo CAR-T Therapy: Azalea Therapeutics' Mouse Study

Azalea Therapeutics has conducted a mouse study demonstrating the engineering of CAR-T cells in vivo through precise gene editing, which may enhance cost efficiency and accessibility in cancer treatment.

Editorial Staff Mar 18

Life

ARPA-H's Development of FDA-Authorized AI Agents for Clinical Use

ARPA-H is advancing the deployment of AI agents in hospitals, focusing on FDA authorization and clinical trials to enhance healthcare delivery.

Editorial Staff Mar 18

Life

UniQure-FDA Dispute: Implications for Huntington's Research

A Huntington's researcher offers insights into the ongoing UniQure-FDA dispute, highlighting potential impacts on gene therapy and regulatory frameworks.

Editorial Staff Mar 18

Life

Study Links Premature Menopause to Increased Heart Disease Risk

A recent study published in JAMA Cardiology indicates a 40% increase in heart disease risk associated with premature menopause, notably affecting Black women at higher rates.

Editorial Staff Mar 18

Life

Impact of Health Care Fraud Crackdown on Disability Services

The Trump administration's efforts to combat health care fraud are raising concerns among advocates for the disability community, who feel disproportionately targeted.

Editorial Staff Mar 18

Life

Examining Current Medical Challenges Through the Lens of Two Practicing Doctors

The latest Morning Rounds newsletter highlights insights from two doctors addressing contemporary challenges in the medical field, alongside a case of out-of-network billing.

Editorial Staff Mar 18